A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -15.01% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -19.66%. Over the past 30 days, the price of DYN has leaped by -4.65%. And in the last five days, it has fallen by -11.90%.
The current stock price for Dyne Therapeutics Inc. (DYN) is $9.85. The stock experienced a significant increase during the last trading session, reaching $10.06 after opening at $9.24. It dipped to a low of $9.10 before ultimately closing at $9.26.
The market performance of Dyne Therapeutics Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $15.60 on 03/06/23, with the lowest value for the same timeframe being $8.04, recorded on 04/11/23.
52-week price history of DYN Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Dyne Therapeutics Inc.’s current trading price is -36.86% away from its 52-week high, while its distance from the 52-week low is 22.51%. The stock’s price range for this period has been between $8.04 and $15.60. The Healthcare sector company’s shares saw a trading volume of about 0.91 million for the day, which was higher than the average daily volume of 0.52 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Dyne Therapeutics Inc. (DYN) has experienced a quarterly decline of -10.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 606.17M and boasts a workforce of 134 employees.
Expert Opinions: Analysts’ Ratings for Dyne Therapeutics Inc.
As of right now, 8 analysts are rating Dyne Therapeutics Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.72, with a change in price of -0.79. Similarly, Dyne Therapeutics Inc. recorded 496,203 in trading volume during the last 100 days, posting a change of -7.42%.
DYN’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for DYN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
DYN Stock Stochastic Average
As of today, the raw stochastic average of Dyne Therapeutics Inc. over the last 50 days is at 31.23%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 31.23%. Further, the company’s Stochastic %K and %D values for the last 20 days were 21.88% and 18.11%, respectively.